Investigational Drug Details
| Drug ID: | D545 |
| Drug Name: | Abrocitinib |
| Synonyms: | |
| Type: | small molecule |
| DrugBank ID: | DB14973 |
| DrugBank Description: | Abrocitinib is under investigation in clinical trial NCT03796676 (JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis). |
| PubChem ID: | 78323835 |
| CasNo: | 1622902-68-4 |
| Repositioning for NAFLD: | Yes |
| SMILES: | CCCS(=O)(=O)N[C@H]1C[C@H](C1)N(C)C1=C2C=CNC2=NC=N1 |
| Structure: |
|
| InChiKey: | IUEWXNHSKRWHDY-PHIMTYICSA-N |
| Molecular Weight: | 323.42 |
| DrugBank Targets: | Tyrosine-protein kinase JAK1; Tyrosine-protein kinase JAK2; Tyrosine-protein kinase JAK3; Non-receptor tyrosine-protein kinase TYK2 |
| DrugBank MoA: | |
| DrugBank Pharmacology: | |
| DrugBank Indication: | |
| Targets: | |
| Therapeutic Category: | |
| Clinical Trial Progress: | |
| Latest Progress: |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|